Novartis Ag (NVS) Capital Expenditures (2009 - 2026)
Novartis Ag recorded quarterly Capital Expenditures of -$346.0 million in Q1 2026, up 43.19% quarter-over-quarter from -$609.0 million in Q4 2025, and down 36.22% year-over-year from -$542.5 million in Q1 2025.
Novartis Ag's Capital Expenditures history runs 18 years deep, the most recent figure standing at -$346.0 million for Q1 2026.
- In Q1 2026, Capital Expenditures fell 36.22% year-over-year to -$346.0 million; the TTM figure through Mar 2026 stood at -$1.6 billion (down 17.73% YoY), while the FY2025 annual figure was $1.5 billion, up 13.32% from the prior year.
- Capital Expenditures came in at -$346.0 million for Q1 2026 at Novartis Ag, up from -$609.0 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of -$168.0 million in Q1 2023 to a low of -$609.0 million in Q4 2025.
- A 5-year average of -$315.4 million and a median of -$261.0 million in 2023 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures jumped 37.04% in 2022 and tumbled 37.44% in 2024, its largest moves.
- Novartis Ag's Capital Expenditures stood at -$306.0 million in 2022, then tumbled by 32.68% to -$406.0 million in 2023, then sank by 37.44% to -$558.0 million in 2024, then dropped by 9.14% to -$609.0 million in 2025, then jumped by 43.19% to -$346.0 million in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered -$346.0 million, -$609.0 million, and -$354.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | -346.00 Mn |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 2.33 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 1.05 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 265.00 Mn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 991.00 Mn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 712.00 Mn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 117.00 Mn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 436.00 Mn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 347.00 Mn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -346.00 Mn |
| Mar 31, 2026 | -346.00 Mn |
| Dec 31, 2025 | -609.00 Mn |
| Dec 31, 2025 | -609.00 Mn |
| Sep 30, 2025 | -354.00 Mn |
| Sep 30, 2025 | -354.00 Mn |
| Jun 30, 2025 | -331.00 Mn |
| Jun 30, 2025 | -331.00 Mn |
| Mar 31, 2025 | -254.00 Mn |
| Mar 31, 2025 | -254.00 Mn |
| Dec 31, 2024 | -558.00 Mn |
| Dec 31, 2024 | -558.00 Mn |
| Sep 30, 2024 | -321.00 Mn |
| Sep 30, 2024 | -321.00 Mn |
| Jun 30, 2024 | -260.00 Mn |
| Jun 30, 2024 | -260.00 Mn |
| Mar 31, 2024 | -227.00 Mn |
| Mar 31, 2024 | -227.00 Mn |
| Dec 31, 2023 | -406.00 Mn |
| Dec 31, 2023 | -406.00 Mn |
| Sep 30, 2023 | -261.00 Mn |
| Sep 30, 2023 | -261.00 Mn |
| Jun 30, 2023 | -225.00 Mn |
| Jun 30, 2023 | -225.00 Mn |
| Mar 31, 2023 | -168.00 Mn |
| Mar 31, 2023 | -168.00 Mn |
| Dec 31, 2022 | -306.00 Mn |
| Dec 31, 2022 | -306.00 Mn |
| Sep 30, 2022 | -221.00 Mn |
| Sep 30, 2022 | -221.00 Mn |
| Jun 30, 2022 | -257.00 Mn |
| Jun 30, 2022 | -257.00 Mn |
| Mar 31, 2022 | -257.00 Mn |
| Mar 31, 2022 | -257.00 Mn |
| Dec 31, 2021 | -460.00 Mn |
| Dec 31, 2021 | -460.00 Mn |
| Sep 30, 2021 | -351.00 Mn |
| Sep 30, 2021 | -351.00 Mn |
| Jun 30, 2021 | -321.00 Mn |
| Jun 30, 2021 | -321.00 Mn |
| Mar 31, 2021 | -246.00 Mn |
| Mar 31, 2021 | -246.00 Mn |
| Dec 31, 2020 | -521.00 Mn |
| Dec 31, 2020 | -521.00 Mn |
| Sep 30, 2020 | -279.00 Mn |
| Sep 30, 2020 | -279.00 Mn |
| Jun 30, 2020 | -238.00 Mn |
| Jun 30, 2020 | -238.00 Mn |
| Mar 31, 2020 | -237.00 Mn |
| Mar 31, 2020 | -237.00 Mn |
| Dec 31, 2019 | -461.00 Mn |
| Dec 31, 2019 | -461.00 Mn |
| Sep 30, 2019 | -357.00 Mn |
| Sep 30, 2019 | -357.00 Mn |
| Jun 30, 2019 | -279.00 Mn |
| Jun 30, 2019 | -279.00 Mn |
| Mar 31, 2019 | -282.00 Mn |
| Mar 31, 2019 | -282.00 Mn |
| Dec 31, 2018 | -444.00 Mn |
| Dec 31, 2018 | -444.00 Mn |
| Sep 30, 2018 | -295.00 Mn |
| Sep 30, 2018 | -295.00 Mn |
| Jun 30, 2018 | -257.00 Mn |
| Jun 30, 2018 | -257.00 Mn |
| Mar 31, 2018 | -258.00 Mn |
| Mar 31, 2018 | -258.00 Mn |
| Dec 31, 2017 | -638.00 Mn |
| Dec 31, 2017 | -638.00 Mn |
| Sep 30, 2017 | -382.00 Mn |
| Sep 30, 2017 | -382.00 Mn |
| Jun 30, 2017 | -332.00 Mn |
| Jun 30, 2017 | -332.00 Mn |
| Mar 31, 2017 | -344.00 Mn |
| Mar 31, 2017 | -344.00 Mn |
| Dec 31, 2016 | -586.00 Mn |
| Dec 31, 2016 | -586.00 Mn |
| Sep 30, 2016 | -443.00 Mn |
| Sep 30, 2016 | -443.00 Mn |
| Jun 30, 2016 | -448.00 Mn |
| Jun 30, 2016 | -448.00 Mn |
| Mar 31, 2016 | -385.00 Mn |
| Mar 31, 2016 | -385.00 Mn |
| Dec 31, 2015 | -753.00 Mn |
| Dec 31, 2015 | -753.00 Mn |
| Sep 30, 2015 | -579.00 Mn |
| Sep 30, 2015 | -579.00 Mn |
| Jun 30, 2015 | -566.00 |
| Jun 30, 2015 | -566.00 |
| Mar 31, 2015 | -469.00 |
| Mar 31, 2015 | -469.00 |
| Dec 31, 2014 | -830.00 |
| Dec 31, 2014 | -830.00 |
| Sep 30, 2014 | -668.00 |
| Sep 30, 2014 | -668.00 |
| Jun 30, 2014 | -644.00 |
| Jun 30, 2014 | -644.00 |
| Mar 31, 2014 | -482.00 |
| Mar 31, 2014 | -482.00 |
| Sep 30, 2013 | -759.00 |
| Sep 30, 2013 | -759.00 |
| Jun 30, 2013 | -633.00 |
| Jun 30, 2013 | -633.00 |
| Mar 31, 2013 | -497.00 |
| Mar 31, 2013 | -497.00 |
| Sep 30, 2012 | -662.00 |
| Sep 30, 2012 | -662.00 |
| Jun 30, 2012 | -604.00 |
| Jun 30, 2012 | -604.00 |
| Mar 31, 2012 | -412.00 |
| Mar 31, 2012 | -412.00 |
| Dec 31, 2011 | -785.00 |
| Dec 31, 2011 | -785.00 |
| Sep 30, 2011 | -510.00 |
| Sep 30, 2011 | -510.00 |
| Jun 30, 2011 | -453.00 |
| Jun 30, 2011 | -453.00 |
| Mar 31, 2011 | -419.00 |
| Mar 31, 2011 | -419.00 |
| Dec 31, 2010 | -673.00 |
| Dec 31, 2010 | -673.00 |
| Sep 30, 2010 | -346.00 |
| Sep 30, 2010 | -346.00 |
| Jun 30, 2010 | -355.00 |
| Jun 30, 2010 | -355.00 |
| Mar 31, 2010 | -304.00 |
| Mar 31, 2010 | -304.00 |
| Dec 31, 2009 | -619.00 |
| Dec 31, 2009 | -619.00 |
| Sep 30, 2009 | -415.00 |
| Sep 30, 2009 | -415.00 |
| Jun 30, 2009 | -485.00 |
| Jun 30, 2009 | -485.00 |
| Mar 31, 2009 | -368.00 |
| Mar 31, 2009 | -368.00 |